The global market for Postoperative Pain Control Drug was estimated to be worth US$ 18130 million in 2023 and is forecast to a readjusted size of US$ 25370 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030

Postoperative Pain Control Drug - Market

Postoperative pain control drugs are medications used to help patients manage pain after surgery. These drugs may be prescribed by a healthcare provider, such as a doctor or anesthesiologist, and are typically administered intravenously or by mouth.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Postoperative Pain Control Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Postoperative Pain Control Drug by region & country, by Type, and by Application.

The Postoperative Pain Control Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Postoperative Pain Control Drug.

Market Segmentation

Scope of Postoperative Pain Control Drug - Market Report

Report Metric	Details
Report Name	Postoperative Pain Control Drug - Market
Forecasted market size in 2030	US$ 25370 million
CAGR	5.1%
Forecasted years	2024 - 2030
Segment by Type:	Opioids NSAIDs Local Anesthetics Tricyclic Antidepressants Antiepileptic Drugs Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Mallinckrodt Pharmaceuticals, Pfizer, Novartis, Eli Lilly, Teva Pharmaceutical Industries, Camurus, Bayer, Pacira BioSciences, Trevena
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Postoperative Pain Control Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Postoperative Pain Control Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Postoperative Pain Control Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Postoperative Pain Control Drug - Market size in 2030?

Ans: The Postoperative Pain Control Drug - Market size in 2030 will be US$ 25370 million.

Who are the main players in the Postoperative Pain Control Drug - Market report?

Ans: The main players in the Postoperative Pain Control Drug - Market are Mallinckrodt Pharmaceuticals, Pfizer, Novartis, Eli Lilly, Teva Pharmaceutical Industries, Camurus, Bayer, Pacira BioSciences, Trevena

What are the Application segmentation covered in the Postoperative Pain Control Drug - Market report?

Ans: The Applications covered in the Postoperative Pain Control Drug - Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

What are the Type segmentation covered in the Postoperative Pain Control Drug - Market report?

Ans: The Types covered in the Postoperative Pain Control Drug - Market report are Opioids, NSAIDs, Local Anesthetics, Tricyclic Antidepressants, Antiepileptic Drugs, Others

1 Market Overview

1.1 Postoperative Pain Control Drug Product Introduction

1.2 Global Postoperative Pain Control Drug Market Size Forecast

1.2.1 Global Postoperative Pain Control Drug Sales Value (2019-2030)

1.2.2 Global Postoperative Pain Control Drug Sales Volume (2019-2030)

1.2.3 Global Postoperative Pain Control Drug Sales Price (2019-2030)

1.3 Postoperative Pain Control Drug Market Trends & Drivers

1.3.1 Postoperative Pain Control Drug Industry Trends

1.3.2 Postoperative Pain Control Drug Market Drivers & Opportunity

1.3.3 Postoperative Pain Control Drug Market Challenges

1.3.4 Postoperative Pain Control Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Postoperative Pain Control Drug Players Revenue Ranking (2023)

2.2 Global Postoperative Pain Control Drug Revenue by Company (2019-2024)

2.3 Global Postoperative Pain Control Drug Players Sales Volume Ranking (2023)

2.4 Global Postoperative Pain Control Drug Sales Volume by Company Players (2019-2024)

2.5 Global Postoperative Pain Control Drug Average Price by Company (2019-2024)

2.6 Key Manufacturers Postoperative Pain Control Drug Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Postoperative Pain Control Drug Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Postoperative Pain Control Drug

2.9 Postoperative Pain Control Drug Market Competitive Analysis

2.9.1 Postoperative Pain Control Drug Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Postoperative Pain Control Drug Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Pain Control Drug as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Opioids

3.1.2 NSAIDs

3.1.3 Local Anesthetics

3.1.4 Tricyclic Antidepressants

3.1.5 Antiepileptic Drugs

3.1.6 Others

3.2 Global Postoperative Pain Control Drug Sales Value by Type

3.2.1 Global Postoperative Pain Control Drug Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Postoperative Pain Control Drug Sales Value, by Type (2019-2030)

3.2.3 Global Postoperative Pain Control Drug Sales Value, by Type (%) (2019-2030)

3.3 Global Postoperative Pain Control Drug Sales Volume by Type

3.3.1 Global Postoperative Pain Control Drug Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Postoperative Pain Control Drug Sales Volume, by Type (2019-2030)

3.3.3 Global Postoperative Pain Control Drug Sales Volume, by Type (%) (2019-2030)

3.4 Global Postoperative Pain Control Drug Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital Pharmacies

4.1.2 Retail Pharmacies

4.1.3 Online Pharmacies

4.1.4 Others

4.2 Global Postoperative Pain Control Drug Sales Value by Application

4.2.1 Global Postoperative Pain Control Drug Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Postoperative Pain Control Drug Sales Value, by Application (2019-2030)

4.2.3 Global Postoperative Pain Control Drug Sales Value, by Application (%) (2019-2030)

4.3 Global Postoperative Pain Control Drug Sales Volume by Application

4.3.1 Global Postoperative Pain Control Drug Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Postoperative Pain Control Drug Sales Volume, by Application (2019-2030)

4.3.3 Global Postoperative Pain Control Drug Sales Volume, by Application (%) (2019-2030)

4.4 Global Postoperative Pain Control Drug Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Postoperative Pain Control Drug Sales Value by Region

5.1.1 Global Postoperative Pain Control Drug Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Postoperative Pain Control Drug Sales Value by Region (2019-2024)

5.1.3 Global Postoperative Pain Control Drug Sales Value by Region (2025-2030)

5.1.4 Global Postoperative Pain Control Drug Sales Value by Region (%), (2019-2030)

5.2 Global Postoperative Pain Control Drug Sales Volume by Region

5.2.1 Global Postoperative Pain Control Drug Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Postoperative Pain Control Drug Sales Volume by Region (2019-2024)

5.2.3 Global Postoperative Pain Control Drug Sales Volume by Region (2025-2030)

5.2.4 Global Postoperative Pain Control Drug Sales Volume by Region (%), (2019-2030)

5.3 Global Postoperative Pain Control Drug Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Postoperative Pain Control Drug Sales Value, 2019-2030

5.4.2 North America Postoperative Pain Control Drug Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Postoperative Pain Control Drug Sales Value, 2019-2030

5.5.2 Europe Postoperative Pain Control Drug Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Postoperative Pain Control Drug Sales Value, 2019-2030

5.6.2 Asia Pacific Postoperative Pain Control Drug Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Postoperative Pain Control Drug Sales Value, 2019-2030

5.7.2 South America Postoperative Pain Control Drug Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Postoperative Pain Control Drug Sales Value, 2019-2030

5.8.2 Middle East & Africa Postoperative Pain Control Drug Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Postoperative Pain Control Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Postoperative Pain Control Drug Sales Value

6.2.1 Key Countries/Regions Postoperative Pain Control Drug Sales Value, 2019-2030

6.2.2 Key Countries/Regions Postoperative Pain Control Drug Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Postoperative Pain Control Drug Sales Value, 2019-2030

6.3.2 United States Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Postoperative Pain Control Drug Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Postoperative Pain Control Drug Sales Value, 2019-2030

6.4.2 Europe Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Postoperative Pain Control Drug Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Postoperative Pain Control Drug Sales Value, 2019-2030

6.5.2 China Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

6.5.3 China Postoperative Pain Control Drug Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Postoperative Pain Control Drug Sales Value, 2019-2030

6.6.2 Japan Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Postoperative Pain Control Drug Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Postoperative Pain Control Drug Sales Value, 2019-2030

6.7.2 South Korea Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Postoperative Pain Control Drug Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Postoperative Pain Control Drug Sales Value, 2019-2030

6.8.2 Southeast Asia Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Postoperative Pain Control Drug Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Postoperative Pain Control Drug Sales Value, 2019-2030

6.9.2 India Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

6.9.3 India Postoperative Pain Control Drug Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Mallinckrodt Pharmaceuticals

7.1.1 Mallinckrodt Pharmaceuticals Company Information

7.1.2 Mallinckrodt Pharmaceuticals Introduction and Business Overview

7.1.3 Mallinckrodt Pharmaceuticals Postoperative Pain Control Drug Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Mallinckrodt Pharmaceuticals Postoperative Pain Control Drug Product Offerings

7.1.5 Mallinckrodt Pharmaceuticals Recent Development

7.2 Pfizer

7.2.1 Pfizer Company Information

7.2.2 Pfizer Introduction and Business Overview

7.2.3 Pfizer Postoperative Pain Control Drug Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Pfizer Postoperative Pain Control Drug Product Offerings

7.2.5 Pfizer Recent Development

7.3 Novartis

7.3.1 Novartis Company Information

7.3.2 Novartis Introduction and Business Overview

7.3.3 Novartis Postoperative Pain Control Drug Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Novartis Postoperative Pain Control Drug Product Offerings

7.3.5 Novartis Recent Development

7.4 Eli Lilly

7.4.1 Eli Lilly Company Information

7.4.2 Eli Lilly Introduction and Business Overview

7.4.3 Eli Lilly Postoperative Pain Control Drug Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Eli Lilly Postoperative Pain Control Drug Product Offerings

7.4.5 Eli Lilly Recent Development

7.5 Teva Pharmaceutical Industries

7.5.1 Teva Pharmaceutical Industries Company Information

7.5.2 Teva Pharmaceutical Industries Introduction and Business Overview

7.5.3 Teva Pharmaceutical Industries Postoperative Pain Control Drug Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Teva Pharmaceutical Industries Postoperative Pain Control Drug Product Offerings

7.5.5 Teva Pharmaceutical Industries Recent Development

7.6 Camurus

7.6.1 Camurus Company Information

7.6.2 Camurus Introduction and Business Overview

7.6.3 Camurus Postoperative Pain Control Drug Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Camurus Postoperative Pain Control Drug Product Offerings

7.6.5 Camurus Recent Development

7.7 Bayer

7.7.1 Bayer Company Information

7.7.2 Bayer Introduction and Business Overview

7.7.3 Bayer Postoperative Pain Control Drug Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Bayer Postoperative Pain Control Drug Product Offerings

7.7.5 Bayer Recent Development

7.8 Pacira BioSciences

7.8.1 Pacira BioSciences Company Information

7.8.2 Pacira BioSciences Introduction and Business Overview

7.8.3 Pacira BioSciences Postoperative Pain Control Drug Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Pacira BioSciences Postoperative Pain Control Drug Product Offerings

7.8.5 Pacira BioSciences Recent Development

7.9 Trevena

7.9.1 Trevena Company Information

7.9.2 Trevena Introduction and Business Overview

7.9.3 Trevena Postoperative Pain Control Drug Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Trevena Postoperative Pain Control Drug Product Offerings

7.9.5 Trevena Recent Development

8 Industry Chain Analysis

8.1 Postoperative Pain Control Drug Industrial Chain

8.2 Postoperative Pain Control Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Postoperative Pain Control Drug Sales Model

8.5.2 Sales Channel

8.5.3 Postoperative Pain Control Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Novartis

Teva Pharmaceutical Industries

Mallinckrodt Pharmaceuticals

Pfizer Inc

Eli Lilly

List of Tables

Table 1. Postoperative Pain Control Drug Market Trends

Table 2. Postoperative Pain Control Drug Market Drivers & Opportunity

Table 3. Postoperative Pain Control Drug Market Challenges

Table 4. Postoperative Pain Control Drug Market Restraints

Table 5. Global Postoperative Pain Control Drug Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Postoperative Pain Control Drug Revenue Market Share by Company (2019-2024)

Table 7. Global Postoperative Pain Control Drug Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Postoperative Pain Control Drug Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Postoperative Pain Control Drug Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Postoperative Pain Control Drug Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Postoperative Pain Control Drug Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Postoperative Pain Control Drug

Table 13. Global Postoperative Pain Control Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Pain Control Drug as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Postoperative Pain Control Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Postoperative Pain Control Drug Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Postoperative Pain Control Drug Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Postoperative Pain Control Drug Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Postoperative Pain Control Drug Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Postoperative Pain Control Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Postoperative Pain Control Drug Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Postoperative Pain Control Drug Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Postoperative Pain Control Drug Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Postoperative Pain Control Drug Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Postoperative Pain Control Drug Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Postoperative Pain Control Drug Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Postoperative Pain Control Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Postoperative Pain Control Drug Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Postoperative Pain Control Drug Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Postoperative Pain Control Drug Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Postoperative Pain Control Drug Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Postoperative Pain Control Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Postoperative Pain Control Drug Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Postoperative Pain Control Drug Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Postoperative Pain Control Drug Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Postoperative Pain Control Drug Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Postoperative Pain Control Drug Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Postoperative Pain Control Drug Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Postoperative Pain Control Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Postoperative Pain Control Drug Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Postoperative Pain Control Drug Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Postoperative Pain Control Drug Sales Value by Region (2019-2024) & (%)

Table 44. Global Postoperative Pain Control Drug Sales Value by Region (2025-2030) & (%)

Table 45. Global Postoperative Pain Control Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Postoperative Pain Control Drug Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Postoperative Pain Control Drug Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Postoperative Pain Control Drug Sales Volume by Region (2019-2024) & (%)

Table 49. Global Postoperative Pain Control Drug Sales Volume by Region (2025-2030) & (%)

Table 50. Global Postoperative Pain Control Drug Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Postoperative Pain Control Drug Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Postoperative Pain Control Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Postoperative Pain Control Drug Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Postoperative Pain Control Drug Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Postoperative Pain Control Drug Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Postoperative Pain Control Drug Sales Volume, (2025-2030) & (K Units)

Table 57. Mallinckrodt Pharmaceuticals Company Information

Table 58. Mallinckrodt Pharmaceuticals Introduction and Business Overview

Table 59. Mallinckrodt Pharmaceuticals Postoperative Pain Control Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Mallinckrodt Pharmaceuticals Postoperative Pain Control Drug Product Offerings

Table 61. Mallinckrodt Pharmaceuticals Recent Development

Table 62. Pfizer Company Information

Table 63. Pfizer Introduction and Business Overview

Table 64. Pfizer Postoperative Pain Control Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Pfizer Postoperative Pain Control Drug Product Offerings

Table 66. Pfizer Recent Development

Table 67. Novartis Company Information

Table 68. Novartis Introduction and Business Overview

Table 69. Novartis Postoperative Pain Control Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Novartis Postoperative Pain Control Drug Product Offerings

Table 71. Novartis Recent Development

Table 72. Eli Lilly Company Information

Table 73. Eli Lilly Introduction and Business Overview

Table 74. Eli Lilly Postoperative Pain Control Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Eli Lilly Postoperative Pain Control Drug Product Offerings

Table 76. Eli Lilly Recent Development

Table 77. Teva Pharmaceutical Industries Company Information

Table 78. Teva Pharmaceutical Industries Introduction and Business Overview

Table 79. Teva Pharmaceutical Industries Postoperative Pain Control Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Teva Pharmaceutical Industries Postoperative Pain Control Drug Product Offerings

Table 81. Teva Pharmaceutical Industries Recent Development

Table 82. Camurus Company Information

Table 83. Camurus Introduction and Business Overview

Table 84. Camurus Postoperative Pain Control Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Camurus Postoperative Pain Control Drug Product Offerings

Table 86. Camurus Recent Development

Table 87. Bayer Company Information

Table 88. Bayer Introduction and Business Overview

Table 89. Bayer Postoperative Pain Control Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Bayer Postoperative Pain Control Drug Product Offerings

Table 91. Bayer Recent Development

Table 92. Pacira BioSciences Company Information

Table 93. Pacira BioSciences Introduction and Business Overview

Table 94. Pacira BioSciences Postoperative Pain Control Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Pacira BioSciences Postoperative Pain Control Drug Product Offerings

Table 96. Pacira BioSciences Recent Development

Table 97. Trevena Company Information

Table 98. Trevena Introduction and Business Overview

Table 99. Trevena Postoperative Pain Control Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Trevena Postoperative Pain Control Drug Product Offerings

Table 101. Trevena Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Postoperative Pain Control Drug Downstream Customers

Table 105. Postoperative Pain Control Drug Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Postoperative Pain Control Drug Product Picture

Figure 2. Global Postoperative Pain Control Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Postoperative Pain Control Drug Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Postoperative Pain Control Drug Sales Volume (2019-2030) & (K Units)

Figure 5. Global Postoperative Pain Control Drug Sales Price (2019-2030) & (US$/Unit)

Figure 6. Postoperative Pain Control Drug Report Years Considered

Figure 7. Global Postoperative Pain Control Drug Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Postoperative Pain Control Drug Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Postoperative Pain Control Drug Revenue in 2023

Figure 10. Postoperative Pain Control Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Opioids Picture

Figure 12. NSAIDs Picture

Figure 13. Local Anesthetics Picture

Figure 14. Tricyclic Antidepressants Picture

Figure 15. Antiepileptic Drugs Picture

Figure 16. Others Picture

Figure 17. Global Postoperative Pain Control Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Postoperative Pain Control Drug Sales Value Market Share by Type, 2023 & 2030

Figure 19. Global Postoperative Pain Control Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 20. Global Postoperative Pain Control Drug Sales Volume Market Share by Type, 2023 & 2030

Figure 21. Global Postoperative Pain Control Drug Price by Type (2019-2030) & (US$/Unit)

Figure 22. Product Picture of Hospital Pharmacies

Figure 23. Product Picture of Retail Pharmacies

Figure 24. Product Picture of Online Pharmacies

Figure 25. Product Picture of Others

Figure 26. Global Postoperative Pain Control Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 27. Global Postoperative Pain Control Drug Sales Value Market Share by Application, 2023 & 2030

Figure 28. Global Postoperative Pain Control Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 29. Global Postoperative Pain Control Drug Sales Volume Market Share by Application, 2023 & 2030

Figure 30. Global Postoperative Pain Control Drug Price by Application (2019-2030) & (US$/Unit)

Figure 31. North America Postoperative Pain Control Drug Sales Value (2019-2030) & (US$ Million)

Figure 32. North America Postoperative Pain Control Drug Sales Value by Country (%), 2023 VS 2030

Figure 33. Europe Postoperative Pain Control Drug Sales Value (2019-2030) & (US$ Million)

Figure 34. Europe Postoperative Pain Control Drug Sales Value by Country (%), 2023 VS 2030

Figure 35. Asia Pacific Postoperative Pain Control Drug Sales Value (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Postoperative Pain Control Drug Sales Value by Country (%), 2023 VS 2030

Figure 37. South America Postoperative Pain Control Drug Sales Value (2019-2030) & (US$ Million)

Figure 38. South America Postoperative Pain Control Drug Sales Value by Country (%), 2023 VS 2030

Figure 39. Middle East & Africa Postoperative Pain Control Drug Sales Value (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Postoperative Pain Control Drug Sales Value by Country (%), 2023 VS 2030

Figure 41. Key Countries/Regions Postoperative Pain Control Drug Sales Value (%), (2019-2030)

Figure 42. Key Countries/Regions Postoperative Pain Control Drug Sales Volume (%), (2019-2030)

Figure 43. United States Postoperative Pain Control Drug Sales Value, (2019-2030) & (US$ Million)

Figure 44. United States Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

Figure 45. United States Postoperative Pain Control Drug Sales Value by Application (%), 2023 VS 2030

Figure 46. Europe Postoperative Pain Control Drug Sales Value, (2019-2030) & (US$ Million)

Figure 47. Europe Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

Figure 48. Europe Postoperative Pain Control Drug Sales Value by Application (%), 2023 VS 2030

Figure 49. China Postoperative Pain Control Drug Sales Value, (2019-2030) & (US$ Million)

Figure 50. China Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

Figure 51. China Postoperative Pain Control Drug Sales Value by Application (%), 2023 VS 2030

Figure 52. Japan Postoperative Pain Control Drug Sales Value, (2019-2030) & (US$ Million)

Figure 53. Japan Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

Figure 54. Japan Postoperative Pain Control Drug Sales Value by Application (%), 2023 VS 2030

Figure 55. South Korea Postoperative Pain Control Drug Sales Value, (2019-2030) & (US$ Million)

Figure 56. South Korea Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

Figure 57. South Korea Postoperative Pain Control Drug Sales Value by Application (%), 2023 VS 2030

Figure 58. Southeast Asia Postoperative Pain Control Drug Sales Value, (2019-2030) & (US$ Million)

Figure 59. Southeast Asia Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

Figure 60. Southeast Asia Postoperative Pain Control Drug Sales Value by Application (%), 2023 VS 2030

Figure 61. India Postoperative Pain Control Drug Sales Value, (2019-2030) & (US$ Million)

Figure 62. India Postoperative Pain Control Drug Sales Value by Type (%), 2023 VS 2030

Figure 63. India Postoperative Pain Control Drug Sales Value by Application (%), 2023 VS 2030

Figure 64. Postoperative Pain Control Drug Industrial Chain

Figure 65. Postoperative Pain Control Drug Manufacturing Cost Structure

Figure 66. Channels of Distribution (Direct Sales, and Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35Z18485

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28M18423

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Moclobemide Film-coated Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-9U15196

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global ADHD Medications Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-14K1494

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions